A KPMG-Leavitt Partners report shows Medicare Advantage and Managed Medicaid are on slightly different trajectories. Expert Ash Shehata shares his predictions for both markets.
How are generic prices changing, how will biosimilars impact costs, and what changes out of Washington should healthcare executives watch? Economics guru Joe Fuhr weighs in.
By recognizing and address the needs of the “whole person,” we have an opportunity to improve the health of people across the U.S. Here are two ways to do that.
A new study reveals an important spillover effect of parental Medicaid coverage.
A new study has shocking findings about death rates in heart failure patients enrolled in the Hospital Readmissions Reduction Program.
Patients who lack resources likely won’t have improved health outcomes even with interventions. Some plans are exploring how to address the problem.
Avalere Health analysis has intriguing results about beneficiaries enrolled in diabetes-focused chronic condition special needs plans.
As legislative discussions begin regarding the reauthorization of CHIP, it is imperative to keep in mind how proposed cuts could be detrimental to the health and future of our nation’s children.
New data presented at the International AIDS Society Conference examines the medical and financial burden of missing pills.
As the nation debates the future of our healthcare system, one idea gaining attention is a “Medicare-for-all” single-payer national health insurance plan.